Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-121063
Filing Date
2024-11-05
Accepted
2024-11-05 07:00:18
Documents
48
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20240930.htm   iXBRL 10-Q 982522
2 EX-31.1 nerv-ex31_1.htm EX-31.1 14992
3 EX-31.2 nerv-ex31_2.htm EX-31.2 14555
4 EX-32.1 nerv-ex32_1.htm EX-32.1 11731
  Complete submission text file 0000950170-24-121063.txt   4483832

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nerv-20240930.xsd EX-101.SCH 811391
51 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20240930_htm.xml XML 569595
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 241425576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)